1 |
Manfredi M, Gismondi P, Iuliano S. Is Helicobacter pylori Anyway Pathogen in Children? Inquiry 2023;60:469580231154650. [PMID: 36803205 DOI: 10.1177/00469580231154650] [Reference Citation Analysis]
|
2 |
Han B, Kim HJ, Yhim H, Oh D, Bae SH, Shin H, Lee W, Kwon J, Lee J, Kim HJ, Bang S. Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study. Ann Hematol. [DOI: 10.1007/s00277-022-04782-2] [Reference Citation Analysis]
|
3 |
Crowley E, Hussey S. Helicobacter pylori in Childhood. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00027-x] [Reference Citation Analysis]
|
4 |
Ikuse T, Toda M, Kashiwagi K, Maruyama K, Nagata M, Tokushima K, Ito N, Tokita K, Kyodo R, Hosoi K, Jimbo K, Kudo T, Shimizu T. Efficacy of Helicobacter pylori Eradication Therapy on Platelet Recovery in Pediatric Immune Thrombocytopenic Purpura-Case Series and a Systematic Review. Microorganisms 2020;8:E1457. [PMID: 32977477 DOI: 10.3390/microorganisms8101457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
5 |
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780-817. [PMID: 31770441 DOI: 10.1182/bloodadvances.2019000812] [Cited by in Crossref: 313] [Cited by in F6Publishing: 334] [Article Influence: 104.3] [Reference Citation Analysis]
|
6 |
Takase K, Nagai H, Kadono M, Yoshioka T, Yoshio N, Hirabayashi Y, Ito T, Sawamura M, Yokoyama A, Yoshida S, Tsutsumi I, Otsuka M, Suehiro Y, Hidaka M, Yoshida I, Yokoyama H, Inoue H, Iida H, Nakayama M, Hishita T, Iwasaki H, Kada A, Saito AM, Kuroda Y. High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura. Int J Hematol 2020;111:388-95. [PMID: 31897888 DOI: 10.1007/s12185-019-02808-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
7 |
Eghbali A, Siavashan VR, Bagheri B, Rahimi Afzal R. Impact of Helicobacter pylori Eradication in Children with Acute Immune Thrombocytopenia: A Randomized Controlled Study. Arch Pediatr Infect Dis 2019;7. [DOI: 10.5812/pedinfect.90522] [Reference Citation Analysis]
|
8 |
Moghimi M, Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Mortazavi Y, Razavi-dizaji S, Keyhanian S, Ghadimi Z, Baba Ali S, Mazloomzadeh S, Jafari S, Mansouri R, Asadi-khiavi M, Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran, Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Dept. of Internal Medicine, Faculty of Medicine, Azad University of Tonekabon, Tonekabon, Iran, Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran, Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Dept. of Pharmacotherapy, Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran. Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP). J Adv Med Biomed Res 2019;27:1-7. [DOI: 10.30699/jambs.27.124.1] [Reference Citation Analysis]
|
9 |
Okuda M, Lin Y, Kikuchi S. Helicobacter pylori Infection in Children and Adolescents. Adv Exp Med Biol 2019;1149:107-20. [PMID: 31037557 DOI: 10.1007/5584_2019_361] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
|
10 |
Kim BJ, Kim HS, Jang HJ, Kim JH. Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials. Gastroenterol Res Pract. 2018;2018:6090878. [PMID: 30402091 DOI: 10.1155/2018/6090878] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
11 |
Xiong LJ, Mao M. Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children. World J Clin Pediatr 2016; 5(1): 82-88 [PMID: 26862506 DOI: 10.5409/wjcp.v5.i1.82] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
12 |
Hojsak I. Helicobacter pylori Gastritis and Peptic Ulcer Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_12] [Reference Citation Analysis]
|
13 |
Amiri M. Impact of Helicobacter pylori Eradication Therapy on Platelet Counts in Patients With Chronic Idiopathic Thrombocytopenic Purpura. Glob J Health Sci 2015;8:35-40. [PMID: 26925898 DOI: 10.5539/gjhs.v8n7p35] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
14 |
Naderi M, Shahraki T, Dorgalaleh A, Tabibian S. Eradication of Gastric Infection by Helicobacter pylori and Chronic Idiopathic Thrombocytopenic Purpura Situation. Gene Cell Tissue 2015;2. [DOI: 10.17795/gct27818] [Reference Citation Analysis]
|
15 |
Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus 2014;23:554-67. [PMID: 24763539 DOI: 10.1177/0961203313499959] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
|
16 |
Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol 2014; 20(36): 12818-12838 [PMID: 25278680 DOI: 10.3748/wjg.v20.i36.12818] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
|
17 |
Brito HS, Braga JA, Loggetto SR, Machado RS, Granato CF, Kawakami E. Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial. Platelets 2015;26:336-41. [PMID: 24832381 DOI: 10.3109/09537104.2014.911836] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
|
18 |
Pacifico L, Osborn JF, Tromba V, Romaggioli S, Bascetta S, Chiesa C. Helicobacter pylori infection and extragastric disorders in children: a critical update. World J Gastroenterol 2014;20:1379-401. [PMID: 24587617 DOI: 10.3748/wjg.v20.i6.1379] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
19 |
Pacifico L, Osborn JF, Tromba V, Romaggioli S, Bascetta S, Chiesa C. Helicobacter pylori infection and extragastric disorders in children: A critical update. World J Gastroenterol 2014; 20(6): 1379-1401 [PMID: 24587617 DOI: 10.3748/wjg.v20.i6.1379] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
|
20 |
Kuwana M. Helicobacter pylori-associated immune thrombocytopenia: Clinical features and pathogenic mechanisms. World J Gastroenterol 2014; 20(3): 714-723 [PMID: 24574745 DOI: 10.3748/wjg.v20.i3.714] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
|
21 |
Braga JA, Loggetto SR, Hoepers AT, Bernardo WM, Medeiros L, Veríssimo MP. Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012. Rev Bras Hematol Hemoter 2013;35:358-65. [PMID: 24255621 DOI: 10.5581/1516-8484.20130105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
22 |
Sierra MS, Hastings EV, Goodman KJ. What do we know about benefits of H. pylori treatment in childhood? Gut Microbes 2013;4:549-67. [PMID: 24280768 DOI: 10.4161/gmic.27000] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
|
23 |
Teawtrakul N, Sawadpanich K, Sirijerachai C, Chansung K, Wanitpongpun C. Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura. Platelets. 2014;25:548-551. [PMID: 24176049 DOI: 10.3109/09537104.2013.841883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
24 |
Kim SY, Cho B. Helicobacter pylori Infection and Hematologic Diseases. Korean J Helicobacter Up Gastrointest Res 2013;13:214. [DOI: 10.7704/kjhugr.2013.13.4.214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
25 |
Tan HJ, Goh KL. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis 2012;13:342-9. [PMID: 22713083 DOI: 10.1111/j.1751-2980.2012.00599.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
|
26 |
Tellería PU. Manejo de la infección por Helicobacter pylori en el niño. Anales de Pediatría Continuada 2012;10:192-200. [DOI: 10.1016/s1696-2818(12)70087-2] [Reference Citation Analysis]
|
27 |
Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, Chong S, Colletti RB, Casswall T, Elitsur Y, Guarner J, Kalach N, Madrazo A, Megraud F, Oderda G; H pylori Working Groups of ESPGHAN and NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 2011;53:230-43. [PMID: 21558964 DOI: 10.1097/MPG.0b013e3182227e90] [Cited by in Crossref: 199] [Cited by in F6Publishing: 193] [Article Influence: 16.6] [Reference Citation Analysis]
|
28 |
Bredlau AL, Semple JW, Segel GB. Management of immune thrombocytopenic purpura in children: potential role of novel agents. Paediatr Drugs 2011;13:213-23. [PMID: 21692546 DOI: 10.2165/11591640-000000000-00000] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
29 |
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190-4207. [PMID: 21325604 DOI: 10.1182/blood-2010-08-302984] [Cited by in Crossref: 1255] [Cited by in F6Publishing: 1344] [Article Influence: 104.6] [Reference Citation Analysis]
|
30 |
Russo G, Miraglia V, Branciforte F, Matarese SM, Zecca M, Bisogno G, Parodi E, Amendola G, Giordano P, Jankovic M, Corti A, Nardi M, Farruggia P, Battisti L, Baronci C, Palazzi G, Tucci F, Ceppi S, Nobili B, Ramenghi U, De Mattia D, Notarangelo L; AIEOP-ITP Study Group. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr Blood Cancer 2011;56:273-8. [PMID: 20830773 DOI: 10.1002/pbc.22770] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
|
31 |
Hussey S, Jones NL. Helicobacter pylori in Childhood. Pediatric Gastrointestinal and Liver Disease 2011. [DOI: 10.1016/b978-1-4377-0774-8.10028-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
32 |
Park JS, Seo J, Youn H, Kang H, Baik S, Lee W, Cho M, Rhee K. Helicobacter pylori Infection and Extraintestinal Manifestations in Children. Korean J Pediatr Gastroenterol Nutr 2011;14:S1. [DOI: 10.5223/kjpgn.2011.14.suppl1.s1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
33 |
Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol 2010; 16(41): 5181-5194 [PMID: 21049552 DOI: 10.3748/wjg.v16.i41.5181] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 71] [Article Influence: 5.0] [Reference Citation Analysis]
|
34 |
Figura N, Franceschi F, Santucci A, Bernardini G, Gasbarrini G, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2010;15 Suppl 1:60-8. [PMID: 21054655 DOI: 10.1111/j.1523-5378.2010.00778.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
|
35 |
Yeh JJ, Tsai S, Wu DC, Wu JY, Liu TC, Chen A. P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection. Blood. 2010;115:4247-4253. [PMID: 20097880 DOI: 10.1182/blood-2009-09-241166] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
|
36 |
Maghbool M, Maghbool M, Shahriari M, Karimi M. Does Helicobacter pylori play a role in the pathogenesis of childhood chronic idiopathic thrombocytopenic purpura? Pediatr Rep 2009;1:e2. [PMID: 21589818 DOI: 10.4081/pr.2009.e2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|